ADC Therapeutics Reports First Quarter 2026 Financial Results and Provides Operational Updates

Arrowhead Pharmaceuticals to Participate in Upcoming May 2026 Events

TE Connectivity maintains position on Dow Jones Best-In-Class Index through continued sustainability, governance efforts

Hubbell to Acquire NSI Industries

BridgeBio to Present New Acoramidis Data on Disease Progression, Biomarkers, and Clinical Outcomes at ESC-Heart Failure 2026

Healthcare Realty Announces Proposed Exchangeable Senior Notes Offering

Twist Bioscience Expands Clonal Genes Offering to Include Long and Complex Sequences

Trulicity Market Size to Reach USD 15.30 Billion by 2035 with Strong Demand for Metabolic Treatments | SNS Insider

Twist Bioscience Announces Fiscal 2026 Second Quarter Financial Results

Compass Diversified Completes Sale of Sterno’s Food Service Business

First Phosphate Receives Funds from Warrant Exercise and Streamlines Capitalization Table

SOLV Energy to Report First Quarter 2026 Financial Results on May 12, 2026

NextEra Energy to meet with investors throughout May and June

Ironwood Survey Findings at DDW 2026 Underscore Need for Therapies that Address Multiple Dimensions of Total Parenteral Nutrition (TPN) Burden in Short Bowel Syndrome (SBS)

Ionis to host 2026 virtual Annual Meeting of Stockholders

NextCure and Simcere Zaiming Initiate Dose Optimization for SIM0505 (CDH6 ADC) in Gynecologic Cancers

Pasithea Therapeutics Announces Appointment of Kartik Krishnan, M.D., Ph.D. as Chief Medical Officer

Middleby Announces Filing of Form 10 Registration Statement for Planned Spin-Off of Middleby Food Processing

Krystal Biotech Announces First Quarter 2026 Financial and Operating Results

ADMA Biologics Announces FDA Approval to Expand the Label for ASCENIV™ to Include Pediatric Immune Compromised Patients Two Years of Age and Older